about
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccinesImpact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6PHIV-1 Tat-based vaccines: from basic science to clinical trials.Effect of MHC haplotype on immune response upon experimental SHIVSF162P4cy infection of Mauritian cynomolgus macaquesInfluence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIVSF162P4cy.Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes.Containment of infection in tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6P(cy243).A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.Interaction of HIV-1 with susceptible lymphoblastoid cells. 1H NMR studies.Circular viral DNA detection and junction sequence analysis from PBMC of SHIV-infected cynomolgus monkeys with undetectable virus plasma RNA.Infection of simian B lymphoblastoid cells with simian immunodeficiency virus is associated with upregulation of CD23 and CD40 cell surface markers.SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine.Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.Mhc haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaques.Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.Tat protein vaccination of cynomolgus macaques influences SHIV-89.6P cy243 epitope variability
P50
Q27333734-5D28C6D4-77A3-4C1F-8278-DFA662446285Q34055475-689DB94D-748E-4E72-8EB1-6112ECEC48C7Q34978901-BA7B2E3B-B242-47D4-9F23-7BBB58EE06BFQ35138516-B359D7C6-013C-431B-933B-79A0C7E257C3Q38915579-69FD5696-893B-4B30-BEEA-7B935BAE149AQ42812312-EF0573E5-CE1E-4084-A25A-2BF5E7CB682BQ43967379-56055095-9E06-40BE-95D3-E35CC2C4F211Q44280840-95F19604-6F0D-4F41-901B-1E4A74F9A7EFQ45263709-15300D57-31D8-4E08-8E87-E85A31AC4F2BQ45625159-7F977E21-7EF2-466C-B0E2-26BA66497CB5Q45731070-F7A8BD1E-C868-4EC7-9863-B9DBA4757565Q45739668-175BAF95-86D6-4408-9183-5DA5C87893FFQ45750307-182B67CA-CA46-4911-9848-0104B4D63ED2Q50849873-1CDE8523-F524-4BB8-A47F-6B6F9A0A0A84Q51998598-3A20D9FC-59A3-463F-A37E-27641C6A284EQ56897975-599F806C-D8AD-4D90-A48A-8CC662FD9A6E
P50
description
researcher, ORCID id # 0000-0001-5058-476X
@en
wetenschapper
@nl
name
Maria Teresa Maggiorella
@ast
Maria Teresa Maggiorella
@en
Maria Teresa Maggiorella
@es
Maria Teresa Maggiorella
@nl
type
label
Maria Teresa Maggiorella
@ast
Maria Teresa Maggiorella
@en
Maria Teresa Maggiorella
@es
Maria Teresa Maggiorella
@nl
prefLabel
Maria Teresa Maggiorella
@ast
Maria Teresa Maggiorella
@en
Maria Teresa Maggiorella
@es
Maria Teresa Maggiorella
@nl
P106
P21
P31
P496
0000-0001-5058-476X